Evaluation of a digital reporting and supporting tool in breast cancer prevention trials (KarmApp)
A vast majority chose to use the KarmApp and reported side effects via the app. More prevalent use was seen among younger participants and use increased over calendar period. Supported by our data, KarmApp exemplifies the potential of using mobile technologies in clinical trials.
Authors
- Jenny Bergqvist
- L. Magnus Bäcklund (ORCID: https://orcid.org/0000-0003-0397-6538)
- Aki Tuuliainen
- Mikael Eriksson (ORCID: https://orcid.org/0000-0001-8135-4270)
- Kamila Czene (ORCID: https://orcid.org/0000-0002-3233-5695)
- Marike Gabrielson (ORCID: https://orcid.org/0000-0002-3171-1556)
- Yvonne Wengström (ORCID: https://orcid.org/0000-0001-8317-7829)
- Mattias Hammarström (ORCID: https://orcid.org/0000-0001-6608-8867)
- José Tapia (ORCID: https://orcid.org/0000-0003-0929-4319)
- Per Hall
Institutions
- Karolinska University Hospital (SE)
- Karolinska Institutet (SE)
- Stockholm South General Hospital (SE)
- Saint Göran Hospital (SE)
Publication Details
- Journal
- BMC Health Services Research
- Published
- 2025-03-05
- DOI
- https://doi.org/10.1186/s12913-025-12471-9
- Primary Topic
- Mobile Health and mHealth Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Karolinska Institutet